APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Cytomegalovirus Envelope Glycoprotein B

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Cytomegalovirus Envelope Glycoprotein B Industry Growth and Trends Forecast to 2032

26 December 202599 pages

Choose your research edition.

Industry ResearchHuman Cytomegalovirus Envelope Glycoprotein B Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Cytomegalovirus Envelope Glycoprotein B Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Human Cytomegalovirus Envelope Glycoprotein B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Cytomegalovirus Envelope Glycoprotein B Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Cytomegalovirus Envelope Glycoprotein B Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Human Cytomegalovirus Envelope Glycoprotein B market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Cytomegalovirus Envelope Glycoprotein B is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Cytomegalovirus Envelope Glycoprotein B is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Cytomegalovirus Envelope Glycoprotein B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Cytomegalovirus Envelope Glycoprotein B include Vical Incorporated, VBI Vaccine Inc, Vakzine Projekt Management GmbH, Trellis Bioscience, Inc. and Astellas Pharma Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Cytomegalovirus Envelope Glycoprotein B market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Cytomegalovirus Envelope Glycoprotein B market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Cytomegalovirus Envelope Glycoprotein B market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Cytomegalovirus Envelope Glycoprotein B.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Cytomegalovirus Envelope Glycoprotein B market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Cytomegalovirus Envelope Glycoprotein B Market by Company

Vical Incorporated

VBI Vaccine Inc

Vakzine Projekt Management GmbH

Trellis Bioscience, Inc.

Astellas Pharma Inc.

Human Cytomegalovirus Envelope Glycoprotein B Segment by Type

CSJ-148

CyMVectin

PPCM

TRL-345

Cytomegalovirus Vaccine

Others

Human Cytomegalovirus Envelope Glycoprotein B Segment by Application

Infectious Disease

Women's Health

Oncology

Others

Human Cytomegalovirus Envelope Glycoprotein B Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Cytomegalovirus Envelope Glycoprotein B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Cytomegalovirus Envelope Glycoprotein B and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Cytomegalovirus Envelope Glycoprotein B.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Cytomegalovirus Envelope Glycoprotein B manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Cytomegalovirus Envelope Glycoprotein B in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of CSJ-148 Table 2. Major Company of CyMVectin Table 3. Major Company of PPCM Table 4. Major Company of TRL-345 Table 5. Major Company of Cytomegalovirus Vaccine Table 6. Major Company of Others Table 7. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2026) & (W Units) Table 9. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Type (2021-2026) Table 10. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2026) & (US$ Million) Table 11. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Type (2021-2026) Table 12. Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2021-2026) & (US$/Unit) Table 13. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2027-2032) & (W Units) Table 14. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Type (2027-2032) Table 15. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2027-2032) & (US$ Million) Table 16. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Type (2027-2032) Table 17. Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2027-2032) & (US$/Unit) Table 18. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2026) & (W Units) Table 19. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2026) & (W Units) Table 21. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2026) & (W Units) Table 23. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2026) & (W Units) Table 25. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2026) & (W Units) Table 27. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2026) & (US$ Million) Table 28. Human Cytomegalovirus Envelope Glycoprotein B Industry Trends Table 29. Human Cytomegalovirus Envelope Glycoprotein B Industry Drivers Table 30. Human Cytomegalovirus Envelope Glycoprotein B Industry Opportunities and Challenges Table 31. Human Cytomegalovirus Envelope Glycoprotein B Industry Restraints Table 32. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Company (2021-2026) Table 34. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Company (2021-2026) & (W Units) Table 35. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Company (2021-2026) Table 36. Global Human Cytomegalovirus Envelope Glycoprotein B Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Human Cytomegalovirus Envelope Glycoprotein B Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Human Cytomegalovirus Envelope Glycoprotein B Major Company Production Sites and Headquarters Table 39. Global Human Cytomegalovirus Envelope Glycoprotein B Company, Product Type & Application Table 40. Global Human Cytomegalovirus Envelope Glycoprotein B Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Human Cytomegalovirus Envelope Glycoprotein B by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2021-2026) & (W Units) Table 45. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Region (2021-2026) Table 46. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2021-2026) & (US$ Million) Table 47. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Region (2021-2026) Table 48. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2027-2032) & (W Units) Table 50. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Region (2027-2032) Table 51. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2027-2032) & (US$ Million) Table 52. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Region (2027-2032) Table 53. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2026) & (W Units) Table 56. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Application (2021-2026) Table 57. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2026) & (US$ Million) Table 58. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Application (2021-2026) Table 59. Global Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2021-2026) & (US$/Unit) Table 60. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2027-2032) & (W Units) Table 61. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Application (2027-2032) Table 62. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2027-2032) & (US$ Million) Table 63. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Application (2027-2032) Table 64. Global Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2027-2032) & (US$/Unit) Table 65. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2026) & (W Units) Table 66. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2026) & (W Units) Table 68. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2026) & (W Units) Table 70. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2026) & (W Units) Table 72. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2026) & (W Units) Table 74. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2026) & (US$ Million) Table 75. Vical Incorporated Company Information Table 76. Vical Incorporated Business Overview Table 77. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio Table 79. Vical Incorporated Recent Development Table 80. VBI Vaccine Inc Company Information Table 81. VBI Vaccine Inc Business Overview Table 82. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio Table 84. VBI Vaccine Inc Recent Development Table 85. Vakzine Projekt Management GmbH Company Information Table 86. Vakzine Projekt Management GmbH Business Overview Table 87. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio Table 89. Vakzine Projekt Management GmbH Recent Development Table 90. Trellis Bioscience, Inc. Company Information Table 91. Trellis Bioscience, Inc. Business Overview Table 92. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio Table 94. Trellis Bioscience, Inc. Recent Development Table 95. Astellas Pharma Inc. Company Information Table 96. Astellas Pharma Inc. Business Overview Table 97. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio Table 99. Astellas Pharma Inc. Recent Development Table 100. North America Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 101. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021-2026) & (W Units) Table 102. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2021-2026) Table 103. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2027-2032) & (W Units) Table 104. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Country (2027-2032) Table 105. North America Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 106. North America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country (2021-2026) & (US$ Million) Table 107. North America Human Cytomegalovirus Envelope Glycoprotein B Market Share by Country (2021-2026) Table 108. North America Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 109. North America Human Cytomegalovirus Envelope Glycoprotein B Market Share Forecast by Country (2027-2032) Table 110. Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 111. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021-2026) & (W Units) Table 112. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2021-2026) Table 113. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2027-2032) & (W Units) Table 114. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Country (2027-2032) Table 115. Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 116. Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country (2021-2026) & (US$ Million) Table 117. Europe Human Cytomegalovirus Envelope Glycoprotein B Market Share by Country (2021-2026) Table 118. Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 119. Europe Human Cytomegalovirus Envelope Glycoprotein B Market Share Forecast by Country (2027-2032) Table 120. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 121. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021-2026) & (W Units) Table 122. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2021-2026) Table 123. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2027-2032) & (W Units) Table 124. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Country (2027-2032) Table 125. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 126. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country (2021-2026) & (US$ Million) Table 127. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Share by Country (2021-2026) Table 128. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 129. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Share Forecast by Country (2027-2032) Table 130. Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 131. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021-2026) & (W Units) Table 132. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2021-2026) Table 133. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2027-2032) & (W Units) Table 134. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Country (2027-2032) Table 135. Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country (2021-2026) & (US$ Million) Table 137. Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Share by Country (2021-2026) Table 138. Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Share Forecast by Country (2027-2032) Table 140. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 141. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021-2026) & (W Units) Table 142. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2021-2026) Table 143. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2027-2032) & (W Units) Table 144. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Country (2027-2032) Table 145. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country (2021-2026) & (US$ Million) Table 147. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Share by Country (2021-2026) Table 148. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Share Forecast by Country (2027-2032) Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Human Cytomegalovirus Envelope Glycoprotein B Distributors List Table 153. Human Cytomegalovirus Envelope Glycoprotein B Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Human Cytomegalovirus Envelope Glycoprotein B Image Figure 2. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (2021-2032) & (W Units) Figure 5. CSJ-148 Image Figure 6. Global CSJ-148 Sales YoY Growth (2021-2032) & (W Units) Figure 7. CyMVectin Image Figure 8. Global CyMVectin Sales YoY Growth (2021-2032) & (W Units) Figure 9. PPCM Image Figure 10. Global PPCM Sales YoY Growth (2021-2032) & (W Units) Figure 11. TRL-345 Image Figure 12. Global TRL-345 Sales YoY Growth (2021-2032) & (W Units) Figure 13. Cytomegalovirus Vaccine Image Figure 14. Global Cytomegalovirus Vaccine Sales YoY Growth (2021-2032) & (W Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 17. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Type 2025 VS 2032 Figure 19. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Type in 2025 Figure 20. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Type in 2025 Figure 21. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Type in 2025 Figure 22. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Type in 2025 Figure 25. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Human Cytomegalovirus Envelope Glycoprotein B Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Infectious Disease Image Figure 32. Global Infectious Disease Sales YoY Growth (2021-2032) & (W Units) Figure 33. Women's Health Image Figure 34. Global Women's Health Sales YoY Growth (2021-2032) & (W Units) Figure 35. Oncology Image Figure 36. Global Oncology Sales YoY Growth (2021-2032) & (W Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 39. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application 2025 VS 2032 Figure 41. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Application in 2025 Figure 42. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Application in 2025 Figure 43. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Application in 2025 Figure 44. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Application in 2025 Figure 47. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Application in 2025 Figure 51. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Human Cytomegalovirus Envelope Glycoprotein B Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Human Cytomegalovirus Envelope Glycoprotein B Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 68. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Human Cytomegalovirus Envelope Glycoprotein B Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Human Cytomegalovirus Envelope Glycoprotein B Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • CSJ-148
  • CyMVectin
  • PPCM
  • TRL-345
  • Cytomegalovirus Vaccine
  • Others
Applications
  • Infectious Disease
  • Women's Health
  • Oncology
  • Others
Companies covered
  • Vical Incorporated
  • VBI Vaccine Inc
  • Vakzine Projekt Management GmbH
  • Trellis Bioscience, Inc.
  • Astellas Pharma Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Cytomegalovirus Envelope Glycoprotein B Market by Type
  6. 1.3.1 CSJ-148
  7. 1.3.2 CyMVectin
  8. 1.3.3 PPCM
  9. 1.3.4 TRL-345
  10. 1.3.5 Cytomegalovirus Vaccine
  11. 1.3.6 Others
  12. 1.4 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type
  13. 1.4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Human Cytomegalovirus Envelope Glycoprotein B Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Human Cytomegalovirus Envelope Glycoprotein B Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Human Cytomegalovirus Envelope Glycoprotein B Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Cytomegalovirus Envelope Glycoprotein B Industry Trends
  2. 2.2 Human Cytomegalovirus Envelope Glycoprotein B Industry Drivers
  3. 2.3 Human Cytomegalovirus Envelope Glycoprotein B Industry Opportunities and Challenges
  4. 2.4 Human Cytomegalovirus Envelope Glycoprotein B Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Cytomegalovirus Envelope Glycoprotein B Sales (2021-2026)
  3. 3.3 Global Top Players by Human Cytomegalovirus Envelope Glycoprotein B Price (2021-2026)
  4. 3.4 Global Human Cytomegalovirus Envelope Glycoprotein B Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Cytomegalovirus Envelope Glycoprotein B Major Company Production Sites & Headquarters
  6. 3.6 Global Human Cytomegalovirus Envelope Glycoprotein B Company, Product Type & Application
  7. 3.7 Global Human Cytomegalovirus Envelope Glycoprotein B Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Cytomegalovirus Envelope Glycoprotein B Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Cytomegalovirus Envelope Glycoprotein B Tier 1, Tier 2, and Tier 3
4 Human Cytomegalovirus Envelope Glycoprotein B Regional Status and Outlook
  1. 4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Historic Market Size by Region
  3. 4.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Cytomegalovirus Envelope Glycoprotein B Forecasted Market Size by Region
  7. 4.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Cytomegalovirus Envelope Glycoprotein B by Application
  1. 5.1 Human Cytomegalovirus Envelope Glycoprotein B Market by Application
  2. 5.1.1 Infectious Disease
  3. 5.1.2 Women's Health
  4. 5.1.3 Oncology
  5. 5.1.4 Others
  6. 5.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application
  7. 5.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Human Cytomegalovirus Envelope Glycoprotein B Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Human Cytomegalovirus Envelope Glycoprotein B Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Vical Incorporated
  2. 6.1.1 Vical Incorporated Company Information
  3. 6.1.2 Vical Incorporated Business Overview
  4. 6.1.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
  6. 6.1.5 Vical Incorporated Recent Developments
  7. 6.2 VBI Vaccine Inc
  8. 6.2.1 VBI Vaccine Inc Company Information
  9. 6.2.2 VBI Vaccine Inc Business Overview
  10. 6.2.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
  12. 6.2.5 VBI Vaccine Inc Recent Developments
  13. 6.3 Vakzine Projekt Management GmbH
  14. 6.3.1 Vakzine Projekt Management GmbH Company Information
  15. 6.3.2 Vakzine Projekt Management GmbH Business Overview
  16. 6.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
  18. 6.3.5 Vakzine Projekt Management GmbH Recent Developments
  19. 6.4 Trellis Bioscience, Inc.
  20. 6.4.1 Trellis Bioscience, Inc. Company Information
  21. 6.4.2 Trellis Bioscience, Inc. Business Overview
  22. 6.4.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
  24. 6.4.5 Trellis Bioscience, Inc. Recent Developments
  25. 6.5 Astellas Pharma Inc.
  26. 6.5.1 Astellas Pharma Inc. Company Information
  27. 6.5.2 Astellas Pharma Inc. Business Overview
  28. 6.5.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
  30. 6.5.5 Astellas Pharma Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country
  2. 7.1.1 North America Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021-2026)
  4. 7.1.3 North America Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
  6. 7.2.1 North America Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country
  2. 8.1.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
  6. 8.2.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Country
  2. 9.1.1 Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
  6. 9.2.1 Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country
  2. 10.1.1 South America Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021-2026)
  4. 10.1.3 South America Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
  6. 10.2.1 South America Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country
  2. 11.1.1 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
  6. 11.2.1 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Cytomegalovirus Envelope Glycoprotein B Value Chain Analysis
  2. 12.1.1 Human Cytomegalovirus Envelope Glycoprotein B Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Cytomegalovirus Envelope Glycoprotein B Production Mode & Process
  7. 12.2 Human Cytomegalovirus Envelope Glycoprotein B Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Cytomegalovirus Envelope Glycoprotein B Distributors
  10. 12.2.3 Human Cytomegalovirus Envelope Glycoprotein B Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst